I-Corps: An Advanced Analytics Platform for Personalized Treatment

I-Corps：用于个性化治疗的高级分析平台

• 批准号: 2330769
• 负责人: Sajal Das
• 金额: $ 5万
• 依托单位: Missouri University of Science and Technology
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-06-01 至 2024-05-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2330769&HistoricalAwards=false
• 关键词: Corps; Advanced; Analytics; Platform; Personalized

The broader impact/commercial potential of this I-Corps project is to revolutionize the current approach to decision-making processes in disease treatment. The project will help transform how patients, their families, and healthcare providers navigate the complex landscape of disease treatment options. It aspires to empower these stakeholders with personalized, data-driven treatment recommendations, considering a comprehensive set of individual patient attributes and real-world variables such as the location, budget, and insurance details. By making disease treatment more personalized and efficient, the project is poised to significantly improve treatment outcomes and reduce healthcare costs. Furthermore, its commercial potential is substantial, given the growing need for personalized healthcare solutions and the rise of artificial intelligence-powered applications in healthcare.This I-Corps project is based on the development of artificial intelligence-powered platform that provides personalized disease treatment recommendations. The innovation lies in leveraging advanced machine learning algorithms to analyze a wide array of patient-specific and disease-specific data, leading to more accurate treatment suggestions tailored to each individual patient's unique circumstances and features. The project aims to address the problem of overwhelming and often confusing treatment options by providing clear, data-backed suggestions via the developed platform. By doing so, it offers an opportunity to enhance the treatment decision-making process and ultimately improve the quality of patient care.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

该 I-Corps 项目更广泛的影响/商业潜力是彻底改变当前疾病治疗决策过程的方法。该项目将有助于改变患者、其家人和医疗保健提供者应对复杂的疾病治疗方案的方式。它渴望为这些利益相关者提供个性化的、数据驱动的治疗建议，同时考虑一整套的个体患者属性和现实世界的变量，如位置、预算和保险细节。通过使疾病治疗更加个性化和高效，该项目有望显着改善治疗结果并降低医疗成本。此外，鉴于对个性化医疗解决方案的需求不断增长以及人工智能驱动的医疗保健应用的兴起，其商业潜力巨大。该 I-Corps 项目基于人工智能驱动的平台的开发，该平台可提供个性化的疾病治疗建议。创新之处在于利用先进的机器学习算法来分析各种患者特定和疾病特定的数据，从而根据每个患者的独特情况和特征提供更准确的治疗建议。该项目旨在通过开发的平台提供清晰的、有数据支持的建议，解决治疗选择过多且经常令人困惑的问题。通过这样做，它提供了一个加强治疗决策过程并最终提高患者护理质量的机会。该奖项反映了 NSF 的法定使命，并通过使用基金会的智力优点和更广泛的影响审查标准进行评估，被认为值得支持。